Abstract
The combination of Eucommia ulmoides and Tribulus terrestris (ET) has been widely utilized in clinical practice for thousands of years, but the mechanism underlying its efficacy has not been elucidated to date. This study attempted to investigate the role played by the intestinal microbiota and fecal metabolism in the response of elderly spontaneous hypertensive rats (SHRs) to ET administration as a treatment for hypertension. Fourteen male spontaneously hypertensive rats (SHRs, 18 months old) were randomly divided into an ET group and an SHR group, and 7 Wistar-Kyoto (WKY) rats of the same age were employed as the control group. The ET group was intragastrically administered 1.0 g/kg/d ET for 42 days, and SHRs and WKY rats were administered an equal amount of normal saline intragastrically. The intestinal microbiota and fecal metabolism were analyzed by 16S rRNA sequencing and the GC-MS (gas chromatography-mass spectrometry)/MS assay. ET treatment decreased blood pressure steadily, improved the colonic tissue morphology, and changed the structure and composition of the imbalanced microbiota in SHRs. Specifically, ET treatment increased the abundance of Eubacterium, which might be one of the target microbes for ET, and had a negative correlation with the levels of α-tocopherol, chenodeoxycholic acid, and deoxycholic acid according to the Spearman correlation analysis. The change in the intestinal microbiota affected the fecal metabolic pattern of SHRs. Eight potential biomarkers were determined to be primarily enriched in ABC transporters, phenylalanine metabolism, central carbon metabolism in cancer, purine metabolism, and protein digestion and absorption. The correlation analysis demonstrated that the abundance of Eubacterium and the decreased levels of α-tocopherol, chenodeoxycholic acid, and deoxycholic acid in the ET group were highly correlated. Our results suggest that ET has a good antihypertensive effect, which may be driven by the intestinal microbiota and their beneficial metabolites. The results of this study may help to elucidate the antihypertensive mechanism of ET.
Highlights
Accumulating evidence indicates that there is a close relationship between the intestinal microbiota and hypertension
It has been suggested that the presence or absence of certain specific groups of intestinal microbiota contributes to immunity [9], nerve conduction [10], and energy supply [11]
spontaneous hypertensive rats (SHRs) in the ET group were given 1.0 g/kg/d ET suspension (i.e., 0:5 g Eucommia ulmoid es + 0:5 g Tribulus terrestris/kg/d) intragastrically, which was equivalent to 0:5 g/kg/d Eucommia ulmoides + 0:5 g/kg/ d Tribulus terrestris in human clinical application, for 6 weeks
Summary
Accumulating evidence indicates that there is a close relationship between the intestinal microbiota and hypertension. The intestinal microbiome, which is considered the second human genome [1, 2], is believed to be closely related to chronic diseases, especially the occurrence and development of hypertension [3,4,5,6]. The overall balance in the composition of the intestinal microbiota is a key factor ensuring normal host functions [7, 8]. It has been suggested that the presence or absence of certain specific groups of intestinal microbiota contributes to immunity [9], nerve conduction [10], and energy supply [11]. Hypertension and imbalances of the intestinal microbiota influence each other, and the hypertensive phenotype can be “transferred” by fecal microbiota transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.